Related Experiment Video
Updated: May 14, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Gynaecological Disorder with Rare Para-Bombay Phenotype: Challenge in Transfusion Support
Nirupama Sahoo1, Sukanta Tripathy1, Soumya Ranjan Panda2
1Department of Immunohematology and Blood Transfusion, Kalinga Institute of Medical Sciences, Medical School of KIIT University, Bhubaneswar, Odisha 751024 India.
None:
Transfusion management in patients with rare blood group phenotypes is a special challenge, especially in surgical cases. We report here the case of a 51-year-old female patient presenting with a huge pseudo-broad ligament fibroid and rare blood group phenotype. Initial serological testing during preoperative workup of the said case revealed BG discrepancies characterized by the O group on cell typing with an extra reaction with pooled 'O' cells on serum typing. A pan-agglutination pattern in antibody screening coupled with a negative direct antiglobulin test and auto-control indicated a Bombay or para-Bombay phenotype. Use of anti-H lectin, saliva secretor study, and antibody screening with cord O cells (Oi) aided in identifying para-Bombay phenotype. Transfusion support in this patient was challenging due to the presence of an anti-IH antibody acting at 37°. One of the major challenges to perioperative care was the unavailability of compatible donor blood units. An autologous transfusion approach was therefore adopted. After the uneventful surgical excision of the fibroid with minimal intraoperative blood loss, one unit of autologous blood was transfused to the patient. This case exemplifies the importance of comprehensive pre-transfusion testing and meticulous planning for patients with rare blood group phenotypes in order to minimize the risk of transfusion reactions and optimize surgical outcomes. Because the rare phenotype of the para-Bombay and transfusion are often problematic, rare donor registries and a heightened degree of clinical awareness will serve to improve patient safety in these instances.
More Related Videos
07:40Co-transplantation of Human Ovarian Tissue with Engineered Endothelial Cells: A Cell-based Strategy Combining Accelerated Perfusion with Direct Paracrine Delivery
Published on: May 16, 2018
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Rh Blood Group
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...